
Noxopharm Issues New Unquoted Equity Securities

I'm PortAI, I can summarize articles.
Noxopharm Ltd. has announced the issuance of new unquoted equity securities, including UNL C Notes and options expiring in 2027. This move is part of a strategic effort to enhance the company's capital structure, which may influence shareholder value and future market strategies. The company's current market cap stands at A$26.01M, with a year-to-date price performance of -1.11% and a consensus rating of 'Buy'.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

